1-855-378-42281-855-378-4228
One of the out-patient rehab alternatives for clients in Dardanelle who are battling with opioid dependence and addiction is called opioid maintenance therapy. Some facilities and doctors are authorized to dispense certain medications to opioid dependent individuals, many of which are opioids also and are habit forming. With low enough amounts the user doesn't experience being high and also does not experience severe cravings and is not experiencing opioid withdrawal. Methadone is the first medication tried for this reason, but there are a few more options currently to select from.
Methadone is an opioid and can be taken at an outpatient medical center licensed to dispense the med, that is taken daily as a pill or liquid. The cost of the med is approximately under $200 per month. Buprenorphine is also an opioid based med, and is in pill form often taken every other day. But different from Methadone which is only be dispensed in highly structured clinics, Buprenorphine can be and is prescribed and administered in doctor's offices. The monthly cost of buprenorphine is around three hundred dollars per month for the generic version of the drug. There is also a type of buprenorphine that contains the ingredient naloxone, which is a drug which reverses the effects of opiates. A person taking this version of the drug, AKA Suboxone, would find it more difficult to get high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced around $450 /month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other drugs mentioned it's an opioid blocker and isn't an opiate. There is an option to take this medication as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents someone from getting high from opioids, and in turn lowers the risk associated with relapse. This daily shot costs anywhere from $1000 to $1200 monthly.
For All Alcohol and Drug Treatment Facilities In Dardanelle, Click Here.
